IP Library › Patent Application 10928533
Patent Application
App. No. 10/928,533

Methods and compositions for treating macular degeneration

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/928,533
Abstract

This invention relates to methods of treating age-related macular degeneration (AMD). In particular, this invention provides methods of treating all forms of wet, age-related macular degeneration. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat wet AMD.

Claims (6)

1 . A method for treating macular degeneration in a patient comprising:

(a) administering a therapeutically effective amount of the anti-VEGF aptamer identified by the following structure

Ligand Component=fCmGmGrArAfUfCmAmGfUmGmAmAfUmGfCfUfUmAfUmAfCmAfUfCfCmG-3′3′−(VEGF ligand)

locally into the eye; and

(b) providing said patient with phototherapy,

wherein the treatment is effective to treat occult, minimally classic, and predominantly classic forms of wet macular degeneration.

Assignments (2)
CHANGE OF NAME Recorded Dec 1, 2005
From: EYETECH PHARMACEUTICALS, INC.
To: (OSI) EYETECH, INC.
Reel/Frame 017081/0840 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2004
From: GUYER, DAVID R.; O'SHAUGHNESSY, DENIS
To: EYETECH PHARMACEUTICALS, INC.
Reel/Frame 015151/0663 →